Publication details
Apolipoprotein E4 Allele in Subjects with COVID-19
| Authors | |
|---|---|
| Year of publication | 2021 |
| Type | Article in Periodical |
| Magazine / Source | GERONTOLOGY |
| MU Faculty or unit | |
| Citation | |
| web | https://www.karger.com/Article/Pdf/516200 |
| Doi | https://doi.org/10.1159/000516200 |
| Keywords | COVID-19; Apolipoprotein E4 Allele |
| Description | We recently read with keen interest a study by Del Ser et al., who suggest that carriers of APOE4 alleles come under increased risk of mild to moderate symptoms of coronavirus disease 2019 (COVID-19) during SARSCoV-2 infection. COVID-19 disease occurs as a consequence of infection with the RNA coronavirus SARSCoV-2. First reported in Wuhan, China, in December 2019, COVID-19 has since spread rapidly and has become a global pandemic. Although highly contagious, the virus is nonetheless associated with relatively low mortality when compared with other coronavirus infections (MERS or SARS). |